A detailed history of Allianz Asset Management Gmb H transactions in Evolus, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 29,300 shares of EOLS stock, worth $409,907. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,300
Previous 51,100 42.66%
Holding current value
$409,907
Previous $827,000 60.94%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

SELL
$10.84 - $17.45 $236,312 - $380,410
-21,800 Reduced 42.66%
29,300 $323,000
Q3 2024

Nov 12, 2024

BUY
$10.66 - $17.48 $544,726 - $893,228
51,100 New
51,100 $827,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $785M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.